NA
CELL

NewEdge Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

NewEdge Advisors’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,923
Closed -$15.9K – 3928
2023
Q3 		$15.9K Sell
15,923
-450
-3% -$345 ﹤0.01% 2435
2023
Q2 		$8.02K Buy
16,373
+694
+4% +$568 ﹤0.01% 2676
2023
Q1 		$18.2K Buy
15,679
+14,776
+1,636% +$27K ﹤0.01% 2373
2022
Q4 		$1.22K Buy
+903
New +$2.38K ﹤0.01% 2981

NewEdge Advisors's CELL Position: Q4 2023 in Review

NewEdge Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 15,923 shares — an estimated $15.9K sold.

NewEdge Advisors first reported a position in CELL in Q4 2022 and held it in 4 quarters. The position peaked at $18.2K in Q1 2023. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • NewEdge Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • NewEdge Advisors sold 15,923 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $15.9K.
  • NewEdge Advisors first reported a position in PhenomeX Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • NewEdge Advisors's PhenomeX Inc. Common Stock position peaked at $18.2K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on NewEdge Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.